Back to Journals » Journal of Hepatocellular Carcinoma » Volume 4

Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

Total article views   Abstract views HTML views PDF downloads Totals
3,936 Dovepress* 3,028 556+ 315 3,584
PubMed Central* 0 352 67 352
Totals 3,028 908 382 3,936
*Since 12 April 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
212 0 0 0 2 210

View citations on PubMed Central and Google Scholar